GEN-001

N/A

Report date: 2024/04/18 11:25:15

Base Information

Drug NameGEN-001
Drug Alias NameGEN-001LR-20011
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionImmunostimulantsBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsSolid tumoursCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenome & Company
China Registration ClassN/A

Develop Information

Active CompaniesGenome & CompanyLG Chem Life Sciences Innovation Center Inc
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsSolid tumoursCarcinoma, Non-Small-Cell Lung +[6] 
Inactive IndicationsBiliary Tract Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A